JUVE Fundamental Analysis - JUVENTUS FOOTBALL CLUB SPA

Fundamental Rating

We assign a fundamental rating of 1 out of 10 to JUVE. JUVE was compared to 45 industry peers in the Entertainment industry. Both the profitability and financial health of JUVE have multiple concerns. JUVE does not seem to be growing, but still is valued expensively.

Quickly go to:

1. Profitability

1.1 Basic Checks

JUVE had negative earnings in the past year.

JUVE had a positive operating cash flow in the past year.

JUVE had negative earnings in each of the past 5 years.

In multiple years JUVE reported negative operating cash flow during the last 5 years.

1.2 Ratios

The Return On Assets of JUVE (-7.34%) is worse than 62.22% of its industry peers.

JUVE has a Return On Equity of -439.14%. This is in the lower half of the industry: JUVE underperforms 75.56% of its industry peers.

		Industry Rank	Sector Rank
ROA	-7.34%
ROE	-439.14%
ROIC	N/A

ROA(3y)-17.17%

ROA(5y)-20.44%

ROE(3y)-409.53%

ROE(5y)-798.75%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

JUVE has a Gross Margin of 88.51%. This is in the better half of the industry: JUVE outperforms 73.33% of its industry peers.

In the last couple of years the Gross Margin of JUVE has remained more or less at the same level.

The Profit Margin and Operating Margin are not available for JUVE so they could not be analyzed.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	88.51%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-0.57%

GM growth 5Y0.02%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

JUVE does not have a ROIC to compare to the WACC, probably because it is not profitable.

Compared to 1 year ago, JUVE has about the same amount of shares outstanding.

JUVE has less shares outstanding than it did 5 years ago.

JUVE has a worse debt/assets ratio than last year.

2.2 Solvency

JUVE has an Altman-Z score of 0.68. This is a bad value and indicates that JUVE is not financially healthy and even has some risk of bankruptcy.

Looking at the Altman-Z score, with a value of 0.68, JUVE is in line with its industry, outperforming 46.67% of the companies in the same industry.

JUVE has a Debt/Equity ratio of 21.46. This is a high value indicating a heavy dependency on external financing.

JUVE's Debt to Equity ratio of 21.46 is on the low side compared to the rest of the industry. JUVE is outperformed by 75.56% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	21.46
Debt/FCF	N/A
Altman-Z	0.68

ROIC/WACCN/A

WACC7.36%

2.3 Liquidity

JUVE has a Current Ratio of 0.47. This is a bad value and indicates that JUVE is not financially healthy enough and could expect problems in meeting its short term obligations.

Looking at the Current ratio, with a value of 0.47, JUVE is doing worse than 84.44% of the companies in the same industry.

JUVE has a Quick Ratio of 0.47. This is a bad value and indicates that JUVE is not financially healthy enough and could expect problems in meeting its short term obligations.

JUVE has a worse Quick ratio (0.47) than 84.44% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	0.47
Quick Ratio	0.47

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

JUVE shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 70.82%, which is quite impressive.

JUVE shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 18.31%.

The Revenue has been growing slightly by 1.84% on average over the past years.

EPS 1Y (TTM)70.82%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-4.89%

Revenue 1Y (TTM)18.31%

Revenue growth 3Y-0.27%

Revenue growth 5Y1.84%

Sales Q2Q%8.62%

3.2 Future

Based on estimates for the next years, JUVE will show a very negative growth in Earnings Per Share. The EPS will decrease by -17.07% on average per year.

JUVE is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.36% yearly.

EPS Next Y-44.39%

EPS Next 2Y17.46%

EPS Next 3Y-17.07%

EPS Next 5YN/A

Revenue Next Year-6.09%

Revenue Next 2Y-2.13%

Revenue Next 3Y-0.94%

Revenue Next 5Y2.36%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for JUVE. In the last year negative earnings were reported.

Also next year JUVE is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

JUVE's Enterprise Value to EBITDA ratio is in line with the industry average.

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	43.41

4.3 Compensation for Growth

A cheap valuation may be justified as JUVE's earnings are expected to decrease with -17.07% in the coming years.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y17.46%

EPS Next 3Y-17.07%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for JUVE!.

		Industry Rank	Sector Rank
Dividend Yield	0%

More info and screens

Find the best dividend stocks

Show peers with best dividend

JUVENTUS FOOTBALL CLUB SPA

BIT:JUVE (1/7/2026, 12:43:39 PM)

2.798

+0 (+0.14%)

Chartmill FA Rating

GICS SectorCommunication Services

GICS IndustryGroupMedia & Entertainment

GICS IndustryEntertainment

Earnings (Last)09-26 2025-09-26/amc

Earnings (Next)02-26 2026-02-26

Inst Owners10.01%

Inst Owner ChangeN/A

Ins OwnersN/A

Ins Owner ChangeN/A

Market Cap1.17B

Revenue(TTM)439.76M

Net Income(TTM)-58.15M

Analysts44

Price Target2.75 (-1.72%)

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	0%

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)2.53%

PT rev (3m)-10.5%

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)0%

EPS NY rev (3m)-260%

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)0%

Revenue NY rev (3m)-3.12%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	2.65
P/FCF	N/A
P/OCF	45.44
P/B	88.12
P/tB	N/A
EV/EBITDA	43.41

EPS(TTM)-0.21

EYN/A

EPS(NY)-0.09

Fwd EYN/A

FCF(TTM)-0.47

FCFYN/A

OCF(TTM)0.06

OCFY2.2%

SpS1.05

BVpS0.03

TBVpS-0.88

PEG (NY)N/A

PEG (5Y)N/A

Graham NumberN/A

Profitability

		Industry Rank	Sector Rank
ROA	-7.34%
ROE	-439.14%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	88.51%
FCFM	N/A

ROA(3y)-17.17%

ROA(5y)-20.44%

ROE(3y)-409.53%

ROE(5y)-798.75%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexgc growth 3YN/A

ROICexgc growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-0.57%

GM growth 5Y0.02%

F-Score6

Asset Turnover0.56

Health

		Industry Rank	Sector Rank
Debt/Equity	21.46
Debt/FCF	N/A
Debt/EBITDA	8.67
Cap/Depr	162.73%
Cap/Sales	50.75%
Interest Coverage	N/A
Cash Conversion	78.39%
Profit Quality	N/A
Current Ratio	0.47
Quick Ratio	0.47
Altman-Z	0.68

F-Score6

WACC7.36%

ROIC/WACCN/A

Cap/Depr(3y)108.07%

Cap/Depr(5y)101.17%

Cap/Sales(3y)37.97%

Cap/Sales(5y)38.64%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)70.82%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-4.89%

EPS Next Y-44.39%

EPS Next 2Y17.46%

EPS Next 3Y-17.07%

EPS Next 5YN/A

Revenue 1Y (TTM)18.31%

Revenue growth 3Y-0.27%

Revenue growth 5Y1.84%

Sales Q2Q%8.62%

Revenue Next Year-6.09%

Revenue Next 2Y-2.13%

Revenue Next 3Y-0.94%

Revenue Next 5Y2.36%

EBIT growth 1Y42.21%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year5602.26%

EBIT Next 3Y302.59%

EBIT Next 5Y135.22%

FCF growth 1Y-31.13%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y155.76%

OCF growth 3YN/A

OCF growth 5YN/A

JUVENTUS FOOTBALL CLUB SPA / JUVE.MI FAQ

What is the fundamental rating for JUVE stock?

ChartMill assigns a fundamental rating of 1 / 10 to JUVE.MI.

What is the valuation status of JUVENTUS FOOTBALL CLUB SPA (JUVE.MI) stock?

ChartMill assigns a valuation rating of 0 / 10 to JUVENTUS FOOTBALL CLUB SPA (JUVE.MI). This can be considered as Overvalued.

How profitable is JUVENTUS FOOTBALL CLUB SPA (JUVE.MI) stock?

JUVENTUS FOOTBALL CLUB SPA (JUVE.MI) has a profitability rating of 1 / 10.

Can you provide the financial health for JUVE stock?

The financial health rating of JUVENTUS FOOTBALL CLUB SPA (JUVE.MI) is 1 / 10.

JUVENTUS FOOTBALL CLUB SPA (JUVE.MI) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens

JUVENTUS FOOTBALL CLUB SPA / JUVE.MI FAQ

What is the fundamental rating for JUVE stock?

What is the valuation status of JUVENTUS FOOTBALL CLUB SPA (JUVE.MI) stock?

How profitable is JUVENTUS FOOTBALL CLUB SPA (JUVE.MI) stock?

Can you provide the financial health for JUVE stock?